Bioinformation · 2014 · 59 citations · 20 references
Life SciencesBiochemistryNeuroscienceDementiaEnzymologyNeurodegenerationAlzheimer DiseaseAmyloid FormationEnzyme InhibitionNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersAlcohol Dehydrogenase InhibitionAlzheimer Disease DementiaAlzheimer Disease ProgressionAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid InhibitionMolecular Docking Analysis
Alzheimer׳s disease (AD) is one of the most common dementias showing slow progressive cognitive decline. Progression of intracerebral accumulation of beta amyloid (Aβ) peptides by the action of amyloid binding alcohol dehydrogenase (ABAD), a mitochondrial enzyme and β-site amyloid precursor protein cleaving enzyme 1 (BACE1) and the degradation of Acetylcholinesterase (AChE) the main pathological characteristics of AD. Therefore, it is of interest to evaluate the importance of fisetin (a flavonol that belongs to the flavonoid group of polyphenols) binding with AChE, ABAD and BACE1 proteins. Docking experiment of fisetin with these proteins using two different tools namely iGEMDOCK and FlexX show significant binding with acceptable binding values. Thus, the potential inhibitory role of fisetin with AD associated proteins is documented.
20
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text
Arup K. Ghose, Vellarkad N. Viswanadhan, John J. Wendoloski · Journal of Combinatorial Chemistry · 1998 · 3K citations
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Joyce W. Lustbader, Maurizio Cirilli, Chang Lin et al. · Science · 2004 · 1.3K citations